One in a Million Study
This study is looking at a medication for the treatment of Fibrodysplasia Ossificans Progressive (FOP), commonly known as Stone Man Syndrome. People with this condition live their lives in fear of minor injuries, which trigger the progression of their condition.
FOP, a rare disease which affects one in two million people, turns connective tissue such as tendons, muscles, and ligaments into bone. Currently there are no approved treatments for FOP, but there are medications to help control symptoms.
It is hoped that this study will lead to the development of new treatments for FOP. This study requires healthy participants to help us investigate how a healthy body metabolises the drug. The data acquired from this important research will then be used for further stages of testing.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!